xanthine has been researched along with Idiopathic Parkinson Disease in 8 studies
7H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-7 is protonated.
9H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Han, C | 1 |
| Xu, Y | 1 |
| Wu, K | 1 |
| Chen, S | 1 |
| Hu, M | 1 |
| Wang, L | 1 |
| Ye, Y | 1 |
| Ye, F | 1 |
| McFarland, NR | 1 |
| Burdett, T | 1 |
| Desjardins, CA | 1 |
| Frosch, MP | 1 |
| Schwarzschild, MA | 1 |
| LeWitt, P | 1 |
| Schultz, L | 1 |
| Auinger, P | 1 |
| Lu, M | 1 |
| Tai, KK | 1 |
| Truong, DD | 1 |
| Daly, JW | 1 |
| Spencer, JP | 1 |
| Jenner, P | 1 |
| Daniel, SE | 1 |
| Lees, AJ | 1 |
| Marsden, DC | 1 |
| Halliwell, B | 1 |
| Loeffler, DA | 1 |
| Camp, DM | 1 |
| Juneau, PL | 1 |
| Harel, E | 1 |
| LeWitt, PA | 1 |
| Kawachi, M | 1 |
| Kono, N | 1 |
| Kiyokawa, H | 1 |
| Mineo, I | 1 |
| Nakajima, H | 1 |
| Shimizu, T | 1 |
| Yorifuji, S | 1 |
| Kuwajima, M | 1 |
| Tarui, S | 1 |
1 review available for xanthine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Caffeine analogs: biomedical impact.
Topics: Alzheimer Disease; Asthma; Biomedical Research; Caffeine; Calcium; Central Nervous System Stimulants | 2007 |
7 other studies available for xanthine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Synthesis and Evaluation of Phenylxanthine Derivatives as Potential Dual A2AR Antagonists/MAO-B Inhibitors for Parkinson's Disease.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cell Survival; Humans; Molecular Structure; M | 2017 |
Postmortem brain levels of urate and precursors in Parkinson's disease and related disorders.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Case-Control Studies; Femal | 2013 |
CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.
Topics: Adult; Age of Onset; Antiparkinson Agents; Biomarkers; Chromatography, High Pressure Liquid; Female; | 2011 |
Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
Topics: Adenosine Triphosphate; Animals; Cell Death; Dose-Response Relationship, Drug; Electron Transport Co | 2002 |
Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8,11,14-Eicosatrienoic Acid; Aged; Aged, 80 and over; Chromatography | 1998 |
Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells.
Topics: Adenine; Adenosine; Animals; Disease Models, Animal; Dopamine; Guanine; Guanosine; Hypoxanthine; Neo | 2000 |
Decreased renal clearance of xanthine and hypoxanthine in a patient with renal hypouricemia: a new defect in renal handling of purines.
Topics: Humans; Hypoxanthine; Hypoxanthines; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; P | 1992 |